Fwd: New strategy found to protect against HIV infection
Published Online July 19, 2010
Science DOI: 10.1126/science.329.5990.374
by Jon Cohen
For the first time ever, a vaginal gel has unequivocally blocked the transmission of HIV. In a trial that involved nearly 900 South African women, those who received a vaginal gel that contains an anti-HIV drug had a 39% lower chance of becoming infected by the virus than those who received a placebo. As reported today online in Science and in a presentation at the 18th International AIDS Conference in Vienna, of the 444 women who received a placebo gel, 60 became infected with HIV, versus 38 infections in the 445 women who received the microbicide. The result was statistically significant, and no serious side effects occurred.
Read more and listen to the podcast at
This e-mail was sent to BCBRAD3@...
To get on and off our e-mail lists, please change your e-mail preferences here.
If you need additional help, please write to memuser@... .
AAAS / Science
1200 New York Avenue NW
Washington, DC 20005
Telephone: +1 202-326-6417
Toll Free in the U.S.: 866-434-(AAAS) 2227
[ AAAS / Science does not endorse any 3rd party products or services advertised here. ]
© 2010 American Association for the Advancement of Science. All Rights Reserved.